SINGAPORE (AP) — SINGAPORE (AP) — Wave Life Sciences Pte. Ltd. (WVE) on Thursday reported a loss of $53.2 million in its fourth quarter.

On a per-share basis, the Singapore-based company said it had a loss of 30 cents.

The results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 28 cents per share.

The biopharmaceutical company posted revenue of $17.2 million in the period, which beat Street forecasts. Seven analysts surveyed by Zacks expected $11.9 million.

For the year, the company reported a loss of $204.4 million, or $1.21 per share. Revenue was reported as $42.7 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on WVE at https://www.zacks.com/ap/WVE